Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Specimen Handling 21Magnetic Resonance Spectroscopy 18Carboplatin 17Gemcitabine 15Cisplatin 12pembrolizumab 11Paclitaxel 11Injections 11Interviews as Topic 10fludarabine 9Radiotherapy 8Oxaliplatin 8Nivolumab 8Fluorouracil 8Dexamethasone 8Cyclophosphamide 8Irinotecan 7Bortezomib 7Biopsy 7Bevacizumab 7toripalimab 6Radiosurgery 6Pemetrexed 6Leucovorin 5Capecitabine 5130-nm albumin-bound paclitaxel 5trastuzumab deruxtecan 4liposomal doxorubicin 4cemiplimab 4X-Rays 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Meropenem × 30 days × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡